CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Leyre Urigüen - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Leyre Urigüen

OPENALEX: A5086408028↗ORCID: 0000-0002-1296-6895↗

Affiliations

Organizations

BioCruces Health research Instituteauthorship · ES Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ES Hospital Universitario 12 De Octubreauthorship · ES Instituto de Salud Carlos IIIauthorship · ES University of the Basque Countryauthorship · ES

Public evidence

4 connected articles

The CB<sub>1</sub> receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls.2024 · Europe PMC Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients.2022 · Europe PMC Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain.2021 · PubMed Central Open Access Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway.2018 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.